Lammek B, Derdowska I, Melin P
Institute of Chemistry, University of Gdańsk, Poland.
Pol J Pharmacol Pharm. 1988 Jul-Aug;40(4):423-8.
The synthesis of three new arginine vasopressin (AVP) analogues with changes at position 1 and 8 is reported. They are: 1-(1-mercapto-4-methylcyclohexaneacetic acid)-8-D-arginine-vasopressin, 1-(4-tert-butyl-1-mercaptocyclohexaneacetic acid)-8-D-arginine-vasopressin and 1-(1-mercapto-4-phenylcyclohexaneacetic acid)-8-D-arginine-vasopressin. They all proved to be potent and selective antagonists of the vasopressor response to AVP. They lacked antagonism in the antidiuretic assay (AD), but retained small agonism in this system. The Arg8 substitution instead of Arg8 in case of the described AVP analogues did not lead to any significant change of antagonistic potency or selectivity.
报道了三种在第1位和第8位有变化的新型精氨酸加压素(AVP)类似物的合成。它们分别是:1-(1-巯基-4-甲基环己烷乙酸)-8-D-精氨酸加压素、1-(4-叔丁基-1-巯基环己烷乙酸)-8-D-精氨酸加压素和1-(1-巯基-4-苯基环己烷乙酸)-8-D-精氨酸加压素。它们均被证明是对AVP升压反应有效的选择性拮抗剂。在抗利尿试验(AD)中它们没有拮抗作用,但在该系统中保留了较小的激动作用。在所描述的AVP类似物中,用精氨酸8取代精氨酸8并没有导致拮抗效力或选择性的任何显著变化。